Central Nervous System

PV QA 2 - Poster Viewing Q&A 2

MO_7_2629 - HER2 Status and Long Term Local Control Following SRS for Breast Cancer Brain Metastases

Monday, October 22
10:45 AM - 12:15 PM
Location: Innovation Hub, Exhibit Hall 3

Naren Ramakrishna, MD, PhD

Biography:
After completing his bachelor of arts in biology at Johns Hopkins University, Dr. Ramakrishna went on to the Medical Scientist Training Program at Cornell University Medical College where he received his medical degree, and a doctorate in Cell Biology and Genetics from Cornell University Graduate School of Medical Sciences.
After an internal medicine internship at Mount Sinai Hospital in New York, he completed a residency in radiation oncology at The Johns Hopkins Hospital, where he was the chief resident. He also completed a Koch Research Fellowship in Gene Therapy at The Johns Hopkins Hospital Oncology Center and Brady Urological Institute and received an AACR-Glaxo Wellcome Oncology Scholar Award.
Dr. Ramakrishna served for eight years on the faculty of Harvard Medical School where he was an Instructor in Radiation Oncology. He was also the Chief of Central Nervous System Radiation Oncology at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, and the Director of the Central Nervous System Radiosurgery/Radiotherapy Fellowship program. He is currently a Professor in Radiation Oncology at the University of Central Florida College of Medicine and a diplomate of both the United States Medical licensing Examination and the American Board of Radiology.
Dr. Ramakrishna is an author of 12 book chapters, and numerous peer-reviewed manuscripts. His current research centers on radiobiological modeling, and SRS and proton therapy for primary and metastastic brain tumors.



Naren Ramakrishna MD, PhD
Director, Proton Therapy, Neuro and Pediatric Radiation Oncology
Orlando Health, UF Health Cancer Center
1400 S. Orange Ave
Orlando 32806

Professor in Radiation Oncology
UCF College of Medicine

Presentation(s):

Send Email for Naren Ramakrishna


Assets

MO_7_2629 - HER2 Status and Long Term Local Control Following SRS for Breast Cancer Brain Metastases



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for HER2 Status and Long Term Local Control Following SRS for Breast Cancer Brain Metastases